Lilly Opens Access to Diabetes Treatment: CVS to Cover Costs
Lilly has announced that millions of Americans will have access to its new diabetes medications, with CVS pharmacy chain covering the costs of GLP-1 drugs like Foundayo and Zepbound. This development could significantly change the lives of many diabetes patients.